Nuzenio

Therapies In Diabetes

Therapies In Diabetes news intelligence with latest source-attributed stories, timeline, related explainers, connected entities, source diversity, and FAQ.

topic 18 latest news signals 17 publisher sources 100/100 entity strength

Latest news

GLP-1RAs Don’t Work Better Than Oral Agents to Enable Insulin Discontinuation in T2D - U.S. MedicineU.S. Medicine · Mon, 10 Aug 2026 00:12:13 GMT Tirzepatide Cuts MACE Risk in Diabetes With Heart Disease - Pharmacy TimesPharmacy Times · Sun, 09 Aug 2026 14:05:20 GMT Bringing best value - Laboratory NewsLaboratory News · Sat, 08 Aug 2026 18:11:19 GMT Claims Data Lend Support to Tirzepatide’s CV Effects in Patients With Diabetes - tctmd.comtctmd.com · Fri, 07 Aug 2026 18:12:28 GMT Diabetes May Worsen Menopause Symptoms, Study Finds—Can GLP-1s Help? - ForbesForbes · Fri, 07 Aug 2026 16:34:55 GMT Experts Uncertain of GLP-1s’ Long-Term Clinical Benefits - Drug TopicsDrug Topics · Fri, 07 Aug 2026 15:09:05 GMT RNA Technology Boosts Survival of Transplanted Islet Cells - RegMedNetRegMedNet · Fri, 07 Aug 2026 13:19:40 GMT Liraglutide combination products using Stevanato Group pen gain European approval - Drug Store NewsDrug Store News · Fri, 07 Aug 2026 12:30:51 GMT

Timeline

Mon, 10 Aug 2026 00:12:13 GMTGLP-1RAs Don’t Work Better Than Oral Agents to Enable Insulin Discontinuation in T2D - U.S. Medicine

Sun, 09 Aug 2026 14:05:20 GMTTirzepatide Cuts MACE Risk in Diabetes With Heart Disease - Pharmacy Times

Sat, 08 Aug 2026 18:11:19 GMTBringing best value - Laboratory News

Fri, 07 Aug 2026 18:12:28 GMTClaims Data Lend Support to Tirzepatide’s CV Effects in Patients With Diabetes - tctmd.com

Fri, 07 Aug 2026 16:34:55 GMTDiabetes May Worsen Menopause Symptoms, Study Finds—Can GLP-1s Help? - Forbes

Fri, 07 Aug 2026 15:09:05 GMTExperts Uncertain of GLP-1s’ Long-Term Clinical Benefits - Drug Topics

Related explainers

HealthHealth stories help readers understand public-health signals, medical research, hospital systems, medicines, disease updates, and safety guidance.HealthcareHealthcare stories can affect personal decisions, so Nuzenio treats them as information that should be checked with original sources and professionals.ElectionsElection stories need careful handling because polls, turnout, legal challenges, and campaign claims can change quickly.

Connected entities

Type6 live mentions GLP5 live mentions Study Finds3 live mentions Drug Store News3 live mentions Alabama3 live mentions Don2 live mentions Work Better Than2 live mentions Oral Agents2 live mentions Enable Insulin Discontinuation2 live mentions Risk2 live mentions

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Therapies In Diabetes.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

17 distinct publisher/source names are currently connected to this entity page.